INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

An expert overview of the literature, useful as background reading.

519 studies · page 8 of 22

2016 / Historical review

A historical review outlines the evolution of obesity treatments from ancient lifestyle advice to modern anti-obesity pharmacotherapies.

This review evaluated the history of obesity treatment from ancient times to the present day using literature searches in PubMed and ClinicalTrials.gov. The authors note that early anti-obesity recommendations focusing on diet, exercise, lifestyle, and emetics originated with Hippocrates and remained mostly unchanged until the early 20th century. Following mid-20th-century amphetamine-based drugs and later regulatory reductions by the 1990s, several new therapies have been approved or are currently in development for long-term treatment.

Haslam D Int J Clin Pract, 2016. PMID 26811245

2016 / Narrative review

Lifestyle changes including diet and exercise form the foundation of obesity management, supplemented by pharmacotherapy and surgery when needed.

This review summarizes modern approaches to obesity management. Foundational to weight loss efforts are lifestyle change, an adhereable high-quality diet, and at least 150 minutes of moderate weekly physical activity. For patients needing additional support, approved medications (such as orlistat, naltrexone/bupropion, liraglutide, lorcaserin, and phentermine/topiramate) and surgical management can improve health and reduce mortality in severe obesity.

Bray GA, Frühbeck G, Ryan DH, et al. Lancet, 2016. PMID 26868660

2016 / Systematic review of intervention trials

Self-weighing is likely to improve weight outcomes without causing negative psychological effects.

This systematic review analyzed 22 articles reporting on 19 intervention trials focused mostly on weight loss or weight gain prevention. Most interventions combined self-weighing with other self-monitoring strategies (64%), utilized daily self-weighing (84%), and lasted up to six months (59%). Improved weight outcomes were demonstrated in 75% of self-weighing-only interventions and 67% of combined interventions that reported efficacy data. No negative psychological effects were observed.

Shieh C, Knisely MR, Clark D, et al. Obes Res Clin Pract, 2016. PMID 26896865

2016 / Narrative review

Cancer cachexia involves systemic metabolic deregulation and tissue wasting that supports tumor growth and directly causes at least 20% of cancer deaths.

This review describes cancer cachexia as a systemic metabolic syndrome wherein tumor growth is supported by tissue wasting and metabolite mobilization. Cachexia causes unstoppable loss of skeletal muscle and fat storage despite adequate caloric intake, leading to nutrient mobilization directly as lipids and amino acids and indirectly as glucose from liver gluconeogenesis. Metabolic dysfunctions include increased insulin and IGF-1 resistance, mitochondrial uncoupling, and fat browning, and cachexia is estimated to be the direct cause of at least 20% of cancer deaths.

Porporato PE Oncogenesis, 2016. PMID 26900952

2016 / Policy review and proposal

Point-of-purchase policies such as portion standards and warning labels are proposed to help prevent obesity and diet-related chronic diseases.

This article discusses how point-of-purchase marketing practices interfere with consumers' ability to eat healthy diets, often working through non-cognitive processes. The authors describe four point-of-purchase policy options: standardized portion sizes, standards for bundled meals (such as 'combo meals'), placement and marketing restrictions on highly processed low-nutrient foods, and explicit warning labels. The authors argue that adopting these policies could significantly contribute to preventing obesity and chronic diseases, noting that many can be implemented locally while preserving consumer choice.

Cohen DA, Lesser LI Obes Rev, 2016. PMID 26910361

2016 / Narrative review essay

A review indicates various antiobesity policies and interventions produce modest beneficial effects on diet, physical activity, and weight.

This essay reviewed the evidence regarding the effectiveness of various antiobesity programs and policies. While some initiatives showed negligible effects, others demonstrated small beneficial impacts on diet, physical activity, and weight. Key findings noted that nutrition and calorie labels led to healthful food reformulations, incentives shifted behaviors in children and adults, and select school-based interventions proved cost-effective. Precommitment mechanisms and bariatric surgery were associated with weight loss, though they may not suit the majority of individuals with obesity.

Cawley J J Health Polit Policy Law, 2016. PMID 26921381

2016 / Editorial / Narrative review

Placebo-related factors may influence outcomes typically attributed to diet and lifestyle interventions in obesity research.

This review examines placebo-related factors (PRFs) and how they may affect outcomes usually attributed to diet and lifestyle interventions in obesity settings. Research participants assigned to placebo-control conditions frequently report improved outcomes and can display physiologic responses resembling those receiving bioactive compounds, even when aware of receiving a placebo. The authors consider environmental and psychosocial influences, including information disclosure, expectations, conditioning, and empathy, and offer suggestions for enhancing PRFs in clinical obesity management.

Fontaine KR, Williams MS, Hoenemeyer TW, et al. Obesity (Silver Spring), 2016. PMID 27028278

2016 / Narrative review

Obesity and hypertension are closely linked, with healthy lifestyle patterns and weight loss serving as primary interventions.

This review examines the obesity-hypertension phenotype, noting that global rates of overweight and obesity have substantially increased. Findings indicate that an increased risk for hypertension is clearly linked to obesity through obesity-induced pathophysiologic adaptations. Primordial prevention focused on lifelong healthy lifestyle patterns is recommended, while treatment requires aggressive focus on weight loss and blood pressure control.

Arena R, Daugherty J, Bond S, et al. Curr Opin Cardiol, 2016. PMID 27070650

2016 / Narrative review

Endoscopic bariatric therapies provide minimally invasive treatment options for obesity and related metabolic comorbidities.

This review evaluates current and emerging endoscopic bariatric therapies for obesity and associated cardio-metabolic comorbidities. Currently, two intragastric balloons have FDA approval for 6-month implantation in patients with a BMI of 30-40 kg/m². Additionally, full-thickness suturing has enabled primary endoscopic sleeve gastroplasty and Roux-en-Y gastric bypass revision as viable alternatives to surgery.

Goyal D, Watson RR Curr Gastroenterol Rep, 2016. PMID 27098813

2016 / Narrative review

Obesity is suggested to be the main modifiable risk factor for knee OA and is linked to higher complication rates after TKA, though patients still benefit.

This review examined the relationship between obesity and lower limb osteoarthritis (OA). A proven association exists between obesity and knee OA, with obese patients (BMI > 30 kg/m^2) more likely to require total knee arthroplasty (TKA). Evidence suggests obese patients face higher rates of short- to medium-term complications following TKA—such as wound infection, medical complications, and potentially early revision—but they can still benefit through improved function, quality of life, and satisfaction.

Shows an association, not proof of cause and effect.

Kulkarni K, Karssiens T, Kumar V, et al. Maturitas, 2016. PMID 27180156

2016 / Narrative review of intervention-based literature

Intervention-based evidence supporting or refuting a causal role for daily breakfast consumption in weight management remains limited.

This review evaluated intervention-based studies examining the effects of breakfast consumption, composition, and size on weight management markers and daily food intake. Overall, limited intervention evidence supports or refutes daily breakfast consumption for these outcomes, though evidence is accumulating for higher protein, fiber, and morning energy. However, most trials manipulating breakfast composition failed to control for habitual breakfast patterns or include a breakfast-skipping control group, leaving causal roles unclear.

Leidy HJ, Gwin JA, Roenfeldt CA, et al. Adv Nutr, 2016. PMID 27184285

2016 / Narrative review

Fibrosis appears to be the primary histological predictor of mortality in NAFLD, while cardiovascular disease and cancer represent major causes of death.

This review summarizes the natural history and progression of non-alcoholic fatty liver disease (NAFLD). NAFLD ranges from bland steatosis to non-alcoholic steatohepatitis (NASH), with emerging data indicating that fibrosis is the most important histological predictor of liver- and non-liver-related death. Metabolic syndrome and its components play a key role in the histological progression of NAFLD, while hepatocellular carcinoma in non-cirrhotic liver is associated with metabolic syndrome and male gender. Beyond liver-related outcomes, cardiovascular disease and malignancy represent major causes of death in individuals with NAFLD.

Shows an association, not proof of cause and effect.

Calzadilla Bertot L, Adams LA Int J Mol Sci, 2016. PMID 27213358

2016 / Narrative review

A review indicates RCTs and cohort studies on diet and disease sometimes conflict due to differences in participant risk profiles and follow-up durations.

This narrative review examined eight sets of dietary studies, comparing findings between randomised controlled trials (RCTs) and epidemiological studies (mostly cohort studies) covering blood pressure, body weight, cancer, and heart disease. While some study findings were consistent, others conflicted. The review noted that RCTs frequently enroll high-risk participants or those with disease history and follow them for only weeks or months, whereas cohort studies typically follow healthy subjects for 5 to 15 years. Consequently, RCT findings are not necessarily more reliable than well-designed prospective cohort studies.

Temple NJ Br J Nutr, 2016. PMID 27267302

2016 / Narrative review of randomized controlled trials

Current trial evidence does not show clear effects of eating versus skipping breakfast on body mass, composition, metabolic rate, or diet-induced thermogenesis.

This review summarizes findings from the Bath Breakfast Project exploring morning fasting versus breakfast in lean and obese adults. Current evidence does not support a clear effect of consuming or skipping breakfast on body mass/composition, metabolic rate, or diet-induced thermogenesis. Daily energy intake was either unaffected or slightly lower when omitting breakfast due to compensatory feeding later in the day. However, both lean and obese adults expended less energy during the morning when remaining fasted compared to when consuming a prescribed breakfast, indicating compensatory adjustments in physical activity thermogenesis.

Betts JA, Chowdhury EA, Gonzalez JT, et al. Proc Nutr Soc, 2016. PMID 27292940

2016 / Narrative review

Irregular meal patterns are linked to higher cardiometabolic risk, while regular eating improved insulin and cholesterol in two intervention trials.

This narrative review evaluated observational and intervention studies on irregular meal patterns and cardiometabolic consequences. Few observational studies were found, but most suggested eating meals irregularly is associated with a higher risk of metabolic syndrome and cardiometabolic risk factors such as BMI and blood pressure. Additionally, two randomized controlled trials found that consuming meals regularly for 2 weeks versus an irregular pattern led to lower peak insulin and lower fasting total and LDL-cholesterol in lean and obese women. The authors noted the evidence is limited and highlighted the need for more large-scale studies with detailed dietary assessments.

Pot GK, Almoosawi S, Stephen AM Proc Nutr Soc, 2016. PMID 27327128

2016 / Narrative review of observational studies

Observational evidence links evening energy intake with obesity in several studies, though overall findings vary widely.

This review examined data from cross-sectional surveys and longitudinal cohorts on global trends in time-of-day of energy intake and its relationship with obesity. A wide variation in time-of-day energy distribution was observed across countries and regions. Across eight cross-sectional surveys and two longitudinal cohorts identified for obesity outcomes, associations between time-of-day of energy intake and obesity varied widely, with several studies reporting a positive link between evening energy intake and obesity.

Shows an association, not proof of cause and effect.

Almoosawi S, Vingeliene S, Karagounis LG, et al. Proc Nutr Soc, 2016. PMID 27327252

2016 / Narrative review

Modifying food timing and dietary behaviors may help mitigate genetic risk for chronodisruption and obesity.

This review discusses the relationship between chronodisruption (CD), circadian rhythms, and obesity. While mutations in clock genes are rare in humans (<1% of the population), single nucleotide polymorphisms in clock genes are common and relate to obesity and weight loss. The authors highlight that nutrigenetics and epigenetics show behaviors can interact with genetic risk variants, proposing that modifying what, how, and when we eat can serve as an effective tool to diminish CD and decrease obesity.

Lopez-Minguez J, Gómez-Abellán P, Garaulet M Proc Nutr Soc, 2016. PMID 27339810

2016 / Narrative review

Spinach phytochemicals and bioactives exhibit antioxidant, anti-inflammatory, anti-cancer, anti-obesity, hypoglycemic, and hypolipidemic properties.

This review summarizes the functional properties of spinach (Spinacia oleracea L.) and its bioactives across cell culture, animal, and human studies. Spinach contains phytochemicals and bioactives, such as glycolipids and thylakoids, that scavenge reactive oxygen species, modulate genes involved in metabolism and inflammation, and curb food intake by inducing satiety hormones. These biological activities contribute to anti-cancer, anti-obesity, hypoglycemic, and hypolipidemic properties, though spinach consumption remains relatively low compared to other leafy greens.

Roberts JL, Moreau R Food Funct, 2016. PMID 27353735

2016 / Narrative review

A review proposes that increased hydration can be associated with weight loss through reduced feeding and increased lipolysis.

This mini-review develops the hypothesis that increased hydration promotes body weight loss, primarily through decreased feeding and fat loss via increased lipolysis. The hypothesis is built on animal studies linking renin-angiotensin system manipulations to increased drinking and reduced body weight, as well as an association between chronic hypohydration, elevated angiotensin II, and chronic diseases. Proposed mechanisms involve increased metabolism from hydration expanding cell volume. The author notes that human studies are consistent with this hypothesis for weight loss and reducing risk factors for obesity and type 2 diabetes.

Shows an association, not proof of cause and effect.

Thornton SN Front Nutr, 2016. PMID 27376070

2016 / Narrative review

Evidence suggests the gut microbiota acts as a mediator of dietary impact on host metabolic status and obesity.

This review discusses the role of diet and the gut microbiota in metabolic diseases such as obesity and type 2 diabetes. Findings from animal models and human studies indicate that the gut microbiota mediates dietary impacts on host metabolism. Current research is focusing on establishing causal relationships in humans and developing therapeutic interventions like personalized nutrition.

Sonnenburg JL, Bäckhed F Nature, 2016. PMID 27383980

2016 / Narrative review

A review discusses inflammation as a potential common causal mechanism linking obesity to the promotion of multiple cancer types.

Obesity affects 35% of US adults and increases the risk of many cancer types while being associated with poor outcomes. Clinical management of cancer patients currently remains largely identical between normal weight and obese individuals. This review summarizes literature exploring inflammation as a potential shared causal driver of cancer initiation and progression across different cancer types.

Kolb R, Sutterwala FS, Zhang W Curr Opin Pharmacol, 2016. PMID 27429211

2016 / Comprehensive narrative review

A review indicates plant-based diets support type 2 diabetes management and are associated with lower disease prevalence.

This review summarizes literature supporting the Canadian Diabetes Association's recommendation of plant-based diets (PBDs) for type 2 diabetes medical nutrition therapy. Large observational studies linked PBDs to a lower prevalence of type 2 diabetes. In intervention trials, PBDs were as effective or more effective than other diabetes diets for improving body weight, cardiovascular risk factors, insulin sensitivity, glycated hemoglobin, oxidative stress, and renovascular markers, while reducing the need for diabetes medications.

Rinaldi S, Campbell EE, Fournier J, et al. Can J Diabetes, 2016. PMID 27476051

2016 / Narrative review

Obesity is associated with a significant psychosocial burden alongside medical comorbidities.

This review provides an overview of the psychosocial burden associated with obesity and its comorbidities, which include cardiovascular disease, type 2 diabetes, sleep apnea, osteoarthritis, and cancer. It describes psychological changes commonly seen with weight loss, noting that evaluating psychosocial functioning is key to assessment and treatment planning. A particular focus is placed on psychosocial functioning in individuals with extreme obesity undergoing bariatric surgery.

Shows an association, not proof of cause and effect.

Sarwer DB, Polonsky HM Endocrinol Metab Clin North Am, 2016. PMID 27519139

2016 / Narrative review

Experimental evidence does not support a causal role for eating frequency or breakfast skipping in weight control, but later eating may be detrimental.

This review evaluates the role of energy and nutrient timing in weight control. Observational studies on the topic are largely inconclusive due to methodological limitations. Experimental evidence does not support a causal role for eating frequency or breakfast skipping in weight control. However, emerging evidence suggests that eating irregularity and eating later in the day may be detrimental for weight control, though more studies are needed.

McCrory MA, Shaw AC, Lee JA Endocrinol Metab Clin North Am, 2016. PMID 27519140